Albers Jeffrey W. - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 8, 2025, Albers Jeffrey W.'s relationship to Kymera Therapeutics, Inc. (KYMR) is Director, and currently has 5,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KYMR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Albers Jeffrey W. - Insider Non-Derivative Transactions of KYMR Common Stock

Albers Jeffrey W. - Insider Non-Derivative Transactions at KYMR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 9, 2025	Sell -- (Common Stock)	2252	90.3	0
Dec 9, 2025	Sell -- (Common Stock)	2748	89.32	2252
Dec 9, 2025	M -- (Common Stock)	5000	14.18	5000
Oct 14, 2025	Sell -- (Common Stock)	5000	59.19	0
Oct 14, 2025	M -- (Common Stock)	5000	10.34	5000
Jun 4, 2025	Sell -- (Common Stock)	6349	49	0
Jun 4, 2025	M -- (Common Stock)	6349	10.34	6349
Aug 27, 2024	Sell -- (Common Stock)	5000	49.1	0
Aug 27, 2024	M -- (Common Stock)	5000	10.34	5000
Feb 22, 2024	Sell -- (Common Stock)	4385	39.05	0
Feb 22, 2024	M -- (Common Stock)	4385	10.34	4385
Feb 21, 2024	Sell -- (Common Stock)	615	39.07	0
Feb 21, 2024	M -- (Common Stock)	615	10.34	615
Jan 24, 2024	Sell -- (Common Stock)	10000	30.05	0
Jan 24, 2024	M -- (Common Stock)	10000	10.34	10000